Sanofi-Aventis SA Company Information
Employees at Sanofi-Aventis SA
Showing 13 of 67383| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Trainee | @sanofi.com | - |
VIEW PROFILE | |
| Responsable Pharmacovigilance, Neuropsychiatrie Et Oncologie | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @astrazeneca.com | - |
Malheiro, Sao Paulo | VIEW PROFILE |
| Employee | @sandoz.com | - |
VIEW PROFILE | |
| Key Account Manager | @sanofi.com | - |
Tampere, Western Finland | VIEW PROFILE |
| Specialty Sales Professional | @bms.com | - |
Albany, New York | VIEW PROFILE |
| Sales Control Manager Bu Pharma Integration-Commercial External Partnership Industrial Affairs | @sanofi.com | - |
Rouen, Haute-Normandie | VIEW PROFILE |
| Representante Medico | @sanofi.com | - |
VIEW PROFILE | |
| Chargée de Développement Stage Rh | @sanofi.com | - |
VIEW PROFILE | |
| International Medical Director | @sanofi.com | - |
VIEW PROFILE | |
| Pharmacovigilance Medical Devices | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @sanofi.com | - |
VIEW PROFILE | |
| Artwork Coordinator | @sanofi.com | - |
Romford, Havering | VIEW PROFILE |
Trainee
Responsable Pharmacovigilance, Neuropsychiatrie Et Oncologie
Employee
Malheiro, Sao Paulo Employee
Key Account Manager
Tampere, Western Finland Sales Control Manager Bu Pharma Integration-Commercial External Partnership Industrial Affairs
Rouen, Haute-Normandie Representante Medico
Chargée de Développement Stage Rh
International Medical Director
Pharmacovigilance Medical Devices
Employee
Artwork Coordinator
Romford, Havering 
Enter an employee name to search and verify work emails, phone numbers and social links etc.
Sanofi-Aventis SA's Email Format
We found 3 email formats used by Sanofi-Aventis SA employees. The most common Sanofi-Aventis SA email format is first.last ex.(jane.doe@sanofi.com) being used 93% of the time.
| FORMAT | % | ||
|---|---|---|---|
| First.last | jane.doe@sanofi.com | 93% | |
| First_initial Last | jdoe@sanofi.com | 3% | |
| Others | @sanofi.com | 2% |
